Association of GDF-15, hs-cTnT and NT-proBNP with coronary artery disease in patients undergoing elective angiographyShow others and affiliations
2022 (English)In: Future Cardiology, ISSN 1479-6678, E-ISSN 1744-8298, Vol. 18, no 8, p. 635-646Article in journal (Refereed) Published
Abstract [en]
Aim: This study investigated the association between plasma levels of GDF-15, hs-cTnT and NT-proBNP and the presence of coronary artery disease (CAD) in stable patients referred for elective coronary angiography.
Methods: The outcome of CAD was defined as an ordinal variable with 3 levels. The association between each biomarker and the outcome was tested using the Winell and Lindback method.
Results: In unadjusted analysis of 252 patients, GDF-15 and hs-cTnT were associated with the presence and extent of CAD. In multivariate regression analysis including traditional risk factors, this association was no longer significant.
Conclusion: NT-proBNP, GDF-15 and hs-cTnT plasma levels do not seem to improve the predictive ability of traditional risk factors for CAD in stable patients referred for coronary angiography. Plain language summary: This study aimed to look at a possible association between blood levels of three molecules (GDF-15, hs-cTnT and N-terminal pro B-type natriuretic peptide [NT-proBNP]) and the presence of coronary artery disease (CAD) in stable patients referred for coronary angiography. Three CAD degrees of severity were identified: no CAD, 1- or 2-vessel CAD and 3-vessel or left main CAD. The association between each of the three blood molecules and CAD was studied using a specific statistical method. In the 252 consecutive patients enrolled, the two molecules GDF-15 and hs-cTnT were significantly associated with the presence and extent of CAD, while NT-proBNP was not. However, when the statistical analysis was adjusted for the traditional risk factors of CAD (age, gender, smoking, diabetes, etc.), the association of GDF-15 and hs-cTnT with CAD was no longer significant. NT-proBNP, GDF-15 and hs-cTnT blood levels do not seem to be independent predictive tools for CAD in stable patients referred for coronary angiography.
Place, publisher, year, edition, pages
Future Medicine Ltd Future Medicine, 2022. Vol. 18, no 8, p. 635-646
Keywords [en]
angiography, biomarkers, BNP, coronary artery disease, GDF-15, troponin
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:uu:diva-483948DOI: 10.2217/fca-2021-0137ISI: 000808114200001PubMedID: 35678322OAI: oai:DiVA.org:uu-483948DiVA, id: diva2:1695531
Note
Shared first authorship: Tarek Souaid, Ziad Hijazi
2022-09-142022-09-142025-02-10Bibliographically approved